220 results on '"Curcio, Daniel"'
Search Results
2. Respiratory Syncytial Virus Sequelae Among Adults in High-Income Countries: A Systematic Literature Review and Meta-analysis
3. Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile
4. Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review
5. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries
6. Attributable Cost of Adult Respiratory Syncytial Virus Illness Beyond the Acute Phase
7. Surgical site infection in elective clean and clean-contaminated surgeries in developing countries
8. Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income Countries
9. Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis
10. The Role of Children in the Transmission of SARS-CoV-2, a Shifting Paradigm
11. Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis
12. Pediatric RSV Diagnostic Testing Performance:A Systematic Review and Meta-analysis
13. Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis
14. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study
15. 2207. Rates of Lower Respiratory Tract Infections Among US Adults Aged ≥18 Years With and Without Chronic Medical Conditions
16. “Salvage treatment” for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal
17. Imbalanced Mortality Evidence for Tigecycline: 2011, the Year of the Meta-analysis
18. Skin and Soft Tissue Infections Due to Methicillin-Resistant Staphylococcus aureus: Role of Tigecycline
19. Antibiotic Stewardship: The “Real World” When Resources Are Limited
20. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
21. Burden of invasive group B Streptococcus disease in non-pregnant adults: A systematic review and meta-analysis
22. Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge?
23. Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline Tigecycline and of other antibiotics
24. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry
25. Comment on: Efficacy and safety of tigecycline: a systematic review and meta-analysis
26. Activity of a novel combination against multidrug-resistant nonfermenters: ceftazidime plus NXL104
27. Tigecycline for severe infections: the gap between the warning and the necessity
28. Off-label use of antibiotics in intensive care unit: The multidrug-resistant pathogens challenge
29. Tigecycline Treatment of Critically Ill Patients: The Latinuser Experience
30. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
31. Resistant pathogen-associated skin and skin-structure infections: antibiotic options
32. Off-label use of antibiotics in hospitalized patients: focus on tigecycline
33. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial
34. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective
35. TIGECYCLINE USE IN CRITICALLY ILL OLDER PATIENTS: CASE REPORTS AND CRITICAL ANALYSIS
36. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2.
37. 1498. Assess Risk Factors, Mortality, and Healthcare Utilization Associated with Clostridioides difficile Infection (CDI) in 4 Latin American Countries
38. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
39. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway
40. Antimicrobials : a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
41. Comment on: Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analysis
42. Streptococcus pneumoniae with High-Level Resistance Worldwide: Results from the ATLAS (Antimicrobial Testing Leadership and Surveillance) Database (2004–2015)
43. Antibiotic Treatment of Community-Acquired Pneumonia in Hospitalized Patients in Argentina (2010–2015)
44. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
45. Antimicrobials
46. Imported Dengue in Buenos Aires, Argentina
47. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
48. Antimicrobial stewardship program in a developing country: the epidemiological barrier
49. Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence
50. Risk Factors Associated With Community-Acquired Pneumonia Among Hospitalized Patients: The Impact of Risk Stacking on Long-Term Mortality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.